Andreas Claas, based in Cambridge, GB, is currently a CTO and Co-founder at Cambridge Medixine Ltd.. Andreas Claas brings experience from previous roles at Cambridge Medixine Ltd., VaxEquity Ltd and Labcorp Drug Development. Andreas Claas holds a 1994 - 2001 Master's and PhD thesis studies in Molecular Biology @ DKFZ German Cancer Research Center. With a robust skill set that includes Leadership, Molecular Cytogenetics, Biotech R&D, Molekularbiologie, qPCR and more. Andreas Claas has 2 emails on RocketReach.
Looking for a different Andreas Claas?
Find contact details for 700 million professionals.